Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cho-Lea Tso

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancers|November 12, 2013
Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrenceKazunari Yamada, Jonathan Tso, Fei Ye, et al.
The Journal of Urology|August 21, 2002
CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomographyAllan J Pantuck, Frank Berger, Amnon Zisman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancerAllan J Pantuck, Arndt van Ophoven, Barbara J Gitlitz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinomaBarbara J Gitlitz, Arie S Belldegrun, Amnon Zisman, et al.
Molecular Cancer Research : MCR|September 13, 2006
Primary glioblastomas express mesenchymal stem-like propertiesCho-Lea Tso, Peter Shintaku, James Chen, et al.
The Prostate|April 25, 2003
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor systemStephen J Freedland, Allan J Pantuck, Sun H Paik, et al.
Cancer Research|January 7, 2006
Distinct transcription profiles of primary and secondary glioblastoma subgroupsCho-Lea Tso, William A Freije, Allen Day, et al.
The Prostate|March 18, 2003
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancerStephen J Freedland, David B Seligson, Alvin Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion geneJosé M Hernández, Matthew H T Bui, Ken-Ryu Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2Marc R J Carlson, Whitney B Pope, Steve Horvath, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancers|November 12, 2013
Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrenceKazunari Yamada, Jonathan Tso, Fei Ye, et al.
The Journal of Urology|August 21, 2002
CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomographyAllan J Pantuck, Frank Berger, Amnon Zisman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancerAllan J Pantuck, Arndt van Ophoven, Barbara J Gitlitz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinomaBarbara J Gitlitz, Arie S Belldegrun, Amnon Zisman, et al.
Molecular Cancer Research : MCR|September 13, 2006
Primary glioblastomas express mesenchymal stem-like propertiesCho-Lea Tso, Peter Shintaku, James Chen, et al.
The Prostate|April 25, 2003
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor systemStephen J Freedland, Allan J Pantuck, Sun H Paik, et al.
Cancer Research|January 7, 2006
Distinct transcription profiles of primary and secondary glioblastoma subgroupsCho-Lea Tso, William A Freije, Allen Day, et al.
The Prostate|March 18, 2003
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancerStephen J Freedland, David B Seligson, Alvin Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion geneJosé M Hernández, Matthew H T Bui, Ken-Ryu Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2Marc R J Carlson, Whitney B Pope, Steve Horvath, et al.
Pageof 2